What is LIBTAYO?

LIBTAYO (Lib-TIE-oh) is a prescription medicine used to treat adults with a type of lung cancer called non–small cell lung cancer (NSCLC).

LIBTAYO may be right for adults with advanced NSCLC who have tumors that do not have an abnormal “EGFR,” “ALK,” or “ROS1” gene, and whose NSCLC:

Portrayal of Advanced NSCLC that has not spread outside the chest

Has not spread outside your chest (locally advanced lung cancer)


AND
Portrayal of Advanced NSCLC that cannot be cured by surgery or chemotherapy with radiation

You cannot have surgery or chemotherapy with radiation


OR
Portrayal of Advanced NSCLC that has spread to other areas of the body

Your lung cancer has spread to other areas of your body (metastatic lung cancer)

And LIBTAYO may be used as your first treatment alone if your tumor tests positive for
high “PD-L1” or in combination with chemotherapy that contains a platinum medicine.

ALK=anaplastic lymphoma kinase; EGFR=epidermal growth factor receptor; PD-L1=programmed death ligand 1; ROS1=ROS proto-oncogene 1, receptor tyrosine kinase.

LIBTAYO works with your immune system to help treat advanced NSCLC.

Learn how LIBTAYO works